基于影像组学特征构建和验证创伤性脑损伤患者颅内高压预测模型:基于CENTER-TBI数据的探索性研究
本研究纳入ICU中接受颅内压监测的创伤性脑损伤患者,开发队列来自CENTER-TBI数据库并随机分为训练组和测试组,验证队列来自上海交通大学附属第一人民医院(上海市第一人民医院)。以初始记录ICP≥20 mmHg定义颅内高压,从头部CT提取影像学特征和三类影像组学特征,构建形态学模型、一阶模型、二阶模型、三阶模型和综合模型,并用逻辑回归、随机森林、多层感知机和极端梯度提升四种分类器评估。最佳分类器为逻辑回归,外部验证组中形态学、一阶、二阶、三阶和综合模型的AUC分别为0.75、0.77、0.76、0.86和0.83,F1分数分别为0.54、0.73、0.63、0.72和0.75。作者认为该模型可能作为创伤性脑损伤患者颅内高压预测的一种方法。
要点
- 以初始记录ICP≥20 mmHg定义颅内高压,模型目的是在ICU创伤性脑损伤患者中预测颅内高压。
- 三阶影像组学模型外部验证AUC为0.86、F1分数为0.72,在五个模型中预测效能最高。
- 综合模型外部验证AUC为0.83、F1分数为0.75;形态学模型AUC为0.75、F1分数为0.54。
- 一阶模型外部验证AUC为0.77、F1分数为0.73;二阶模型AUC为0.76、F1分数为0.63。
- 四种分类器中逻辑回归为最佳分类器,上述外部验证结果均基于逻辑回归分类器。
适用人群与场景
- 纳入ICU中接受颅内压监测的创伤性脑损伤患者。
- 开发队列数据来自CENTER-TBI数据库,随机分为训练组和测试组;验证队列数据来自上海交通大学附属第一人民医院(上海市第一人民医院)收治的患者。
诊断标准与关键阈值
- 颅内高压定义:初始记录的颅内压值大于或等于20 mmHg。
研究设计与关键结果
- 研究类型为预测模型开发与外部验证的探索性研究;开发队列来自CENTER-TBI数据库并随机分为训练组和测试组,验证队列来自上海交通大学附属第一人民医院(上海市第一人民医院)。
- 共构建五个模型:形态学模型、一阶模型、二阶模型、三阶模型和综合模型;用逻辑回归、随机森林、多层感知机和极端梯度提升四种分类器评估,最佳分类器为逻辑回归。
- 外部验证组中,逻辑回归分类器下形态学模型AUC为0.75、F1分数为0.54;一阶模型AUC为0.77、F1分数为0.73;二阶模型AUC为0.76、F1分数为0.63;三阶模型AUC为0.86、F1分数为0.72;综合模型AUC为0.83、F1分数为0.75。
证据类型、等级与局限
- 证据类型:基于CENTER-TBI数据的探索性预测模型开发与外部验证研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,基于影像组学特征建立的模型可能作为创伤性脑损伤患者颅内高压预测的一种方法。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Head computed tomography (CT) is a routinely performed examination to assess the intracranial condition of patients with traumatic brain injury (TBI), and radiological findings can help to indicate the presence of intracranial hypertension. At present, the prediction of intracranial hypertension is mainly based on manual discrimination of imaging characteristics. The aim of our study was to establish a model to predict intracranial hypertension via fully automatic CT image segmentation, rigorous radiomic feature extraction and reliable model development and validation.
METHODS: Patients admitted to the intensive care unit (ICU) who underwent intracranial pressure (ICP) monitoring were included in our study. For the development cohort, we extracted data from the CENTER-TBI database and randomly divided the data into a training group and a test group. For the validation cohort, we extracted data from patients admitted to the Shanghai General Hospital. Patients whose initial recorded ICP value was greater than or equal to 20 mmHg were defined as having intracranial hypertension. Radiological features, including imaging characteristics and three categories of radiomic features, were extracted from the head CT. Feature selection was performed for all radiological findings. A morphological model was built on the basis of selected imaging characteristics. First-order, second-order and third-order models were built on the basis of selected radiomic features. A comprehensive model was built on the basis of all selected radiological findings. The performances of these five models were assessed by four classifiers, including logistic regression (LR), random forest (RF), multilayer perceptron (MLP), and extreme gradient boosting (XGB), from which the best classifier was selected. After the process of model training and external validation, we ultimately used the optimal classifier to generate a prediction model with greater predictive power and stability.
RESULTS: Five models were built, including a morphological model, first-order model, second-order model, third-order model and comprehensive model. The optimal classifier was the logistic regression (LR) classifier, with which the morphological, first-order, second-order, third-order and comprehensive models had AUCs of 0.75, 0.77, 0.76, 0.86, and 0.83 and F1 scores of 0.54, 0.73, 0.63, 0.72, and 0.75, respectively, in the external validation group.
CONCLUSIONS: We successfully established a model for predicting intracranial hypertension on the basis of radiomic features. This model may serve as an approach for intracranial hypertension prediction in TBI patients.
参考来源
- Shan Y, Xue Y, Zhu J, et al. Development and validation of intracranial hypertension prediction models based on radiomic features in patients with traumatic brain injury: an exploratory study based on CENTER-TBI data. Crit Care. 2025. PMID: 40050978. doi:10.1186/s13054-025-05328-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。